<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Seizure</id>
	<title>Seizure - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Seizure"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;action=history"/>
	<updated>2026-08-17T22:08:01Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27741&amp;oldid=prev</id>
		<title>Mfrdmanager at 14:05, 13 November 2020</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27741&amp;oldid=prev"/>
		<updated>2020-11-13T14:05:09Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:05, 13 November 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l8&quot; &gt;Line 8:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 8:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]], (5.10) as indicated.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]], (5.10) as indicated.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Sedative Hypnotics&lt;/del&gt;|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Sedative Hypnotics&lt;/del&gt;|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Valium&lt;/ins&gt;|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Valium&lt;/ins&gt;|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Sedative Hypnotics&lt;/del&gt;|LORAZAPAM]] 1 - 2 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Sedative Hypnotics&lt;/del&gt;|LORAZAPAM]] 1 - 2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Ativan&lt;/ins&gt;|LORAZAPAM]] 1 - 2 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Ativan&lt;/ins&gt;|LORAZAPAM]] 1 - 2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Sedative Hypnotics&lt;/del&gt;|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Versed&lt;/ins&gt;|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Refer to Handtevy System for pediatric administration. If no IV access in PEDIATRICS, rectal administration may be used, per Handtevy System.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Refer to Handtevy System for pediatric administration. If no IV access in PEDIATRICS, rectal administration may be used, per Handtevy System.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27540&amp;oldid=prev</id>
		<title>Mfrdmanager: /* 5.12 SEIZURE */</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27540&amp;oldid=prev"/>
		<updated>2018-06-22T13:45:20Z</updated>

		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;5.12 SEIZURE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:45, 22 June 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l9&quot; &gt;Line 9:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 9:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[Sedative Hypnotics|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[Sedative Hypnotics|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR'''''[[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27539&amp;oldid=prev</id>
		<title>Mfrdmanager at 13:44, 22 June 2018</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=27539&amp;oldid=prev"/>
		<updated>2018-06-22T13:44:52Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:44, 22 June 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l9&quot; &gt;Line 9:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 9:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If current seizure activity lasting greater than 10 minutes,&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[Sedative Hypnotics|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** [[Sedative Hypnotics|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;** '''''OR'''''[[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|LORAZAPAM]] 1 - 2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''''OR''''' [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=153&amp;oldid=prev</id>
		<title>Mfrdmanager: Protected &quot;Seizure&quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=153&amp;oldid=prev"/>
		<updated>2018-02-10T14:28:23Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/ems1/index.php?title=Seizure&quot; title=&quot;Seizure&quot;&gt;Seizure&lt;/a&gt;&amp;quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:28, 10 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=152&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;==Section 5 -MEDICAL== ===5.12 SEIZURE===   INITIAL MEDICAL CARE (2.01) - OXYGEN @ 100% via NRB mask: * Institute if...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Seizure&amp;diff=152&amp;oldid=prev"/>
		<updated>2018-02-10T14:28:17Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 5 -MEDICAL== ===5.12 SEIZURE===   &lt;a href=&quot;/ems1/index.php?title=Initial_Medical_Assessment_and_Care&quot; title=&quot;Initial Medical Assessment and Care&quot;&gt;INITIAL MEDICAL CARE&lt;/a&gt; (2.01) - &lt;a href=&quot;/ems1/index.php?title=Medical_Gases&quot; title=&quot;Medical Gases&quot;&gt;OXYGEN&lt;/a&gt; @ 100% via NRB mask: * Institute if...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 5 -MEDICAL==&lt;br /&gt;
===5.12 SEIZURE===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases|OXYGEN]] @ 100% via NRB mask:&lt;br /&gt;
* Institute if patient had a grand mal seizure PTA or is actively having grand mal seizure.&lt;br /&gt;
* Protect airway and protect patient from injury. Vomiting / aspiration precautions. Place nothing in mouth during seizure. Observe type, location and duration of seizure activity.&lt;br /&gt;
* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]], (5.10) as indicated.&lt;br /&gt;
* If current seizure activity lasting greater than 10 minutes,&lt;br /&gt;
** [[Sedative Hypnotics|DIAZEPAM]] 2 - 20 mg Slow IVP for adults, titrated to control seizure activity. If no IV access, administer [[Sedative Hypnotics|DIAZEPAM]] 10 - 20 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site.&lt;br /&gt;
** '''''OR''''' [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 5 mg IV, IM, IO or IN.&lt;br /&gt;
&lt;br /&gt;
* Refer to Handtevy System for pediatric administration. If no IV access in PEDIATRICS, rectal administration may be used, per Handtevy System.&lt;br /&gt;
* Observe patient's sensorium and airway during post-ictal period. Note any injury sustained during seizure and / or any incontinence.&lt;br /&gt;
* If febrile seizure, refer to [[Pediatric Febrile Emergency|PEDIATRIC FEBRILE EMERGENCY PRACTICE PARAMETER]] (7.10).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''''PATIENT REFUSALS'''''&lt;br /&gt;
*If a patient has been treated for seizures, transport is not required if:&lt;br /&gt;
** The patient is stable.&lt;br /&gt;
** The patient has a competent adult that will remain with the patient for hours.&lt;br /&gt;
** The patient understands and agrees to the following instructions to take medication if indicated and call back if necessary.&lt;br /&gt;
* For seizures, the patient cannot have:&lt;br /&gt;
** fever&lt;br /&gt;
** repetitive seizures&lt;br /&gt;
** an unusual seizure for the patient&lt;br /&gt;
** New onset of seizures&lt;br /&gt;
*Any Questions, refer to [[Refusal of Service|REFUSAL OF SERVICE PRACTICE PARAMETER]] (1.03)&lt;br /&gt;
&lt;br /&gt;
[[Category:Medical|0512]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>